Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-027359
Filing Date
2016-11-03
Accepted
2016-11-03 16:12:16
Documents
45
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ttph-10q_20160930.htm 10-Q 1564094
2 EX-31.1 ttph-ex311_7.htm EX-31.1 17277
3 EX-31.2 ttph-ex312_8.htm EX-31.2 17323
4 EX-32.1 ttph-ex321_9.htm EX-32.1 6205
5 EX-32.2 ttph-ex322_6.htm EX-32.2 6218
  Complete submission text file 0001564590-16-027359.txt   4655149

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ttph-20160930.xml EX-101.INS 830753
7 XBRL TAXONOMY EXTENSION SCHEMA ttph-20160930.xsd EX-101.SCH 32774
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttph-20160930_cal.xml EX-101.CAL 25967
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttph-20160930_def.xml EX-101.DEF 105449
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttph-20160930_lab.xml EX-101.LAB 292459
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttph-20160930_pre.xml EX-101.PRE 211801
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Filer) CIK: 0001373707 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35837 | Film No.: 161971716
SIC: 2834 Pharmaceutical Preparations